These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19406445)

  • 1. [Descriptive epidemiology of neuromyelitis optica in the Caribbean basin].
    Cabre P; Gonzalez-Quevedo A; Lannuzel A; Bonnan M; Merle H; Olindo S; Chausson N; Lara-Rodriguez R; Smadja D; Cabrera-Gomez J
    Rev Neurol (Paris); 2009; 165(8-9):676-83. PubMed ID: 19406445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies.
    Cabrera-Gómez JA; Bonnan M; González-Quevedo A; Saiz-Hinarejos A; Marignier R; Olindo S; Graus F; Smadja D; Merle H; Thomas L; Gómez-García A; Cabre P
    Mult Scler; 2009 Jul; 15(7):828-33. PubMed ID: 19498017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental changes and epidemiology of multiple sclerosis in the French West Indies.
    Cabre P
    J Neurol Sci; 2009 Nov; 286(1-2):58-61. PubMed ID: 19520388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromyelitis optica in France: a multicenter study of 125 patients.
    Collongues N; Marignier R; Zéphir H; Papeix C; Blanc F; Ritleng C; Tchikviladzé M; Outteryck O; Vukusic S; Fleury M; Fontaine B; Brassat D; Clanet M; Milh M; Pelletier J; Audoin B; Ruet A; Lebrun-Frenay C; Thouvenot E; Camu W; Debouverie M; Créange A; Moreau T; Labauge P; Castelnovo G; Edan G; Le Page E; Defer G; Barroso B; Heinzlef O; Gout O; Rodriguez D; Wiertlewski S; Laplaud D; Borgel F; Tourniaire P; Grimaud J; Brochet B; Vermersch P; Confavreux C; de Seze J
    Neurology; 2010 Mar; 74(9):736-42. PubMed ID: 20194912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromyelitis optica: effect of gender.
    Wingerchuk DM
    J Neurol Sci; 2009 Nov; 286(1-2):18-23. PubMed ID: 19740485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of neuromyelitis optica with a pediatric onset.
    Collongues N; Marignier R; Zéphir H; Papeix C; Fontaine B; Blanc F; Rodriguez D; Fleury M; Vukusic S; Pelletier J; Audoin B; Thouvenot E; Camu W; Barroso B; Ruet A; Brochet B; Vermersch P; Confavreux C; de Seze J
    Neurology; 2010 Sep; 75(12):1084-8. PubMed ID: 20855851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder.
    Bonnan M; Valentino R; Olindo S; Mehdaoui H; Smadja D; Cabre P
    Mult Scler; 2009 Apr; 15(4):487-92. PubMed ID: 19324982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis.
    Bagherieh S; Afshari-Safavi A; Vaheb S; Kiani M; Ghaffary EM; Barzegar M; Shaygannejad V; Zabeti A; Mirmosayyeb O
    Neurol Sci; 2023 Jun; 44(6):1905-1915. PubMed ID: 36745300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica.
    Weinstock-Guttman B; Miller C; Yeh E; Stosic M; Umhauer M; Batra N; Munschauer F; Zivadinov R; Ramanathan M
    Mult Scler; 2008 Sep; 14(8):1061-7. PubMed ID: 18573816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica.
    Papeix C; Vidal JS; de Seze J; Pierrot-Deseilligny C; Tourbah A; Stankoff B; Lebrun C; Moreau T; Vermersch P; Fontaine B; Lyon-Caen O; Gout O
    Mult Scler; 2007 Mar; 13(2):256-9. PubMed ID: 17439893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMO-IgG and Devic's neuromyelitis optica: a French experience.
    Marignier R; De Sèze J; Vukusic S; Durand-Dubief F; Zéphir H; Vermersch P; Cabre P; Cavillon G; Honnorat J; Confavreux C
    Mult Scler; 2008 May; 14(4):440-5. PubMed ID: 18208892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive functions in neuromyelitis optica.
    Blanc F; Zéphir H; Lebrun C; Labauge P; Castelnovo G; Fleury M; Sellal F; Tranchant C; Dujardin K; Vermersch P; de Seze J
    Arch Neurol; 2008 Jan; 65(1):84-8. PubMed ID: 18195143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A benign form of neuromyelitis optica: does it exist?
    Collongues N; Cabre P; Marignier R; Zéphir H; Papeix C; Audoin B; Lebrun-Frenay C; Pelletier J; Fontaine B; Vermersch P; Confavreux C; de Seze J;
    Arch Neurol; 2011 Jul; 68(7):918-24. PubMed ID: 21747032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An epidemiological study of neuromyelitis optica in Cuba.
    Cabrera-Gómez JA; Kurtzke JF; González-Quevedo A; Lara-Rodríguez R
    J Neurol; 2009 Jan; 256(1):35-44. PubMed ID: 19224310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromyelitis optica: a distinct demyelinating disease of the central nervous system.
    Argyriou AA; Makris N
    Acta Neurol Scand; 2008 Oct; 118(4):209-17. PubMed ID: 18336627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographic and clinical features of neuromyelitis optica: A review.
    Pandit L; Asgari N; Apiwattanakul M; Palace J; Paul F; Leite MI; Kleiter I; Chitnis T;
    Mult Scler; 2015 Jun; 21(7):845-53. PubMed ID: 25921037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays.
    McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Hinson SR; Kryzer TJ; Lucchinetti CF; Weinshenker BG; Wingerchuk DM; Shuster EA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1134-8. PubMed ID: 19752303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.
    Magaña SM; Matiello M; Pittock SJ; McKeon A; Lennon VA; Rabinstein AA; Shuster E; Kantarci OH; Lucchinetti CF; Weinshenker BG
    Neurology; 2009 Feb; 72(8):712-7. PubMed ID: 19237699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-beta(1b) treatment in neuromyelitis optica.
    Tanaka M; Tanaka K; Komori M
    Eur Neurol; 2009; 62(3):167-70. PubMed ID: 19590215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.